Pluri (PLUR) EPS (Basic) Growth (3y) (2013 - 2025)
Pluri (PLUR) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
-43.55% |
| Date | Value |
|---|
| Dec 31, 2025 |
-43.55% |
| Sep 30, 2025 |
-50.68% |
| Jun 30, 2025 |
-52.86% |
| Mar 31, 2025 |
-44.74% |
| Dec 31, 2024 |
-15.95% |
| Sep 30, 2024 |
-44.22% |
| Jun 30, 2024 |
-32.50% |
| Mar 31, 2024 |
-28.14% |
| Dec 31, 2023 |
-25.13% |
| Sep 30, 2023 |
-42.75% |
| Jun 30, 2023 |
-55.36% |
| Mar 31, 2023 |
-53.53% |
| Dec 31, 2022 |
15.66% |
| Sep 30, 2022 |
25.53% |
| Jun 30, 2022 |
18.64% |
| Mar 31, 2022 |
28.83% |
| Dec 31, 2021 |
23.18% |
| Sep 30, 2021 |
22.39% |
| Jun 30, 2021 |
41.85% |
| Mar 31, 2021 |
-263.42% |
